The expression of paxillin in human cholangiocarcinoma, esophageal cancer, hepatocellular carcinoma, and other tumors is significantly higher than in paired normal tissues, but the expression in several tumors, such as renal papillary cell carcinoma and endometrial carcinoma, is opposite. This evidence concerns the gene PXN and hepatocellular carcinoma.